Literature DB >> 25874512

Whole-liver diffusion-weighted MRI histogram analysis: effect of the presence of colorectal hepatic metastases on the remaining liver parenchyma.

Doenja M J Lambregts1, Milou H Martens, Raymond C W Quah, Katerina Nikiforaki, Luc A Heijnen, Cornelis H C Dejong, Geerard L Beets, Kostas Marias, Nickolas Papanikolaou, Regina G H Beets-Tan.   

Abstract

OBJECTIVES: To explore whether whole-liver diffusion-weighted MRI analysis (of the apparently normal liver parenchyma) can help differentiate between patients with colorectal liver metastasis and controls without liver disease.
MATERIALS AND METHODS: Ten patients with colorectal liver metastasis and 10 controls with no focal/diffuse liver disease underwent liver MRI at 1.5 T including diffusion-weighted imaging (DWI; b-values 0, 50, 100, 500, 750, 1000). Apparent diffusion coefficient (ADC) maps were calculated from the DWI images to carry out quantitative diffusion analyses. An experienced reader performed segmentation of the apparently nondiseased liver (excluding metastases/focal liver lesions) on the ADC maps. Histogram ADC parameters were calculated and compared between the patients and the controls.
RESULTS: The mean liver ADC was 0.95×10⁻³ mm²/s for the patients versus 1.03×10⁻³ mm²/s for the controls (P=0.42). The fifth percentile of the ADC was significantly lower for the patients compared with the controls (0.45 vs. 0.69 10⁻³ mm²/s, P=0.01). The SD was significantly higher in the patient group (0.30 vs. 0.22, P<0.001). Median, skewness, kurtosis, and 30th-95th percentile were not significantly different between the two groups. Areas under the receiver operator characteristics curves to differentiate patients with metastatic liver involvement from healthy controls without liver disease were 0.79 for the fifth percentile and 0.95 for the SD.
CONCLUSION: Whole-liver diffusion-weighted MRI histogram analysis showed a significant shift towards lower fifth percentile ADC values and higher SD in patients with colorectal liver metastasis compared with controls without liver disease.

Entities:  

Mesh:

Year:  2015        PMID: 25874512     DOI: 10.1097/MEG.0000000000000316

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

Review 1.  Diffusion-weighted imaging and texture analysis: current role for diffuse liver disease.

Authors:  Sofia Gourtsoyianni; Joao Santinha; Celso Matos; Nikolaos Papanikolaou
Journal:  Abdom Radiol (NY)       Date:  2020-10-16

2.  Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.

Authors:  Daniel Fadaei Fouladi; Manijeh Zarghampour; Pallavi Pandey; Ankur Pandey; Farnaz Najmi Varzaneh; Mounes Aliyari Ghasabeh; Pegah Khoshpouri; Ihab R Kamel
Journal:  Eur Radiol       Date:  2019-06-17       Impact factor: 5.315

3.  Histogram Analysis of Diffusion Kurtosis Magnetic Resonance Imaging for Diagnosis of Hepatic Fibrosis.

Authors:  Ruo-Fan Sheng; Kai-Pu Jin; Li Yang; He-Qing Wang; Hao Liu; Yuan Ji; Cai-Xia Fu; Meng-Su Zeng
Journal:  Korean J Radiol       Date:  2018-08-06       Impact factor: 3.500

4.  Considering tumour volume for motion corrected DWI of colorectal liver metastases increases sensitivity of ADC to detect treatment-induced changes.

Authors:  Ryan Pathak; Jingduo Tian; Neil A Thacker; David M Morris; Hossein Ragheb; Charles Saunders; Mark Saunders; Alan Jackson
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.